Company Overview of Iroko Pharmaceuticals Inc.
Key Executives for Iroko Pharmaceuticals Inc.
|Osagie O. Imasogie Esq.||298 Relationships||Executive Chairman of the Board and Chief Executive Officer||54|
|Fred C. Krieger MBA, CPA||No Relationships||Senior Vice President and Chief Financial Officer||69|
|Moji James||No Relationships||Senior Vice President and General Counsel||49|
|Clarence L. Young M.D.||No Relationships||Senior Vice President and Chief Medical Officer||60|
|Rohit C. Mehta||No Relationships||Senior Vice President of Corporate Development and Alliance Management||56|
Iroko Pharmaceuticals Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Osagie O. Imasogie Esq.||298 Relationships||Iroko Pharmaceuticals Inc.||54|
|Nathan A. Burkey||7 Relationships||Kew Capital LLP||--|
|Jeremy P. A. Fletcher||15 Relationships||Kew Capital LLP||62|
|David C. U'Prichard Ph.D.||125 Relationships||Druid Consulting, LLC||67|
|Louis J. Vollmer||5 Relationships||Iroko Pharmaceuticals, LLC||--|
Iroko Pharmaceuticals Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.